Evaluation of Bone Health in Postmenopausal Women Using Long-Term Levothyroxine Treatment Due to Post-Procedural Hypothyroidism
Mahmut Apaydin, Ferda Surel, Sinan Kazan · 2024
Read Evaluation of Bone Health in Postmenopausal Women Using Long-Term Levothyroxine Treatment Due to Post-Procedural Hypothyroidism by Mahmut Apaydin, Ferda Surel, Sinan Kazan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11648544.txt.
Description
Mahmut Apaydin, Ferda Surel, and Sinan Kazan checked bone health in women on long-term thyroid hormone after thyroid removal in a 2024 study. Levothyroxine replaces the hormone the gland no longer makes. Too much hormone, though, is suspected of thinning bone, and studies of fracture risk have clashed.
Their patients were postmenopausal women, a group already at raised osteoporosis risk. The team evaluated bone measures under prolonged treatment to separate drug effects from menopause effects. The answer guides dosing: replacement should restore normal levels without quietly taxing the skeleton. Endocrine doctors get local evidence for a dilemma they meet weekly, balancing hormone sufficiency against bone safety over decades of use.
Catalog record
| CREATOR | Mahmut Apaydin, Ferda Surel, Sinan Kazan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 14 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |